A New Jersey-based drug company is recalling thousands of bottles of medication for high blood pressure after they failed to meet federal quality standards.

The recall affects bottles of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide manufactured by Macleods Pharma USA and distributed nationwide.

It covers 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B; both lots expire 31 May 2027.

all 3 comments

sorted by: hot top controversial new old
[–] 5 points 1 week ago

Man, this report really boils my blood.

  • source
  • [–] 7 points 1 week ago (1 child)

    Doctor who is asked to recall it:

    "Ahh yes, I remember that one".

  • source
  • hideshow 1 child comment